Journal of Medicinal Chemistry · 2023 · 10 citations · 23 references
PharmacyInfectious DiseasesPharmacologyClinical PharmacologyDrug DeliveryOral Drug DeliveryAntiviral AgentsAntiviral PharmacologyAntiviral PharmacotherapyAntiviral TherapyLipid-based Oral FormulationsAntiviral Safety AssessmentAntiviral Structure-activity RelationshipsAntiviral TherapeuticsEfficacy Against Severe DiseaseOral Drug BioavailabilityOral TreatmentSars-cov-2 Antiviral TherapySars-cov-2 Infection
High Resolution Image Download MS PowerPoint Slide Early antiviral treatments, including intravenous remdesivir (RDV), reduce hospitalization and severe disease caused by COVID-19. An orally bioavailable RDV analog may facilitate earlier treatment of non-hospitalized COVID-19 patients. Here we describe the synthesis and evaluation of alkyl glyceryl ether phosphodiesters of GS-441524 (RVn), lysophospholipid analogs which allow for oral bioavailability and stability in plasma. Oral treatment of SARS-CoV-2-infected BALB/c mice with 1- O -octadecyl-2- O -benzyl- sn -glyceryl-3- phospho -RVn (60 mg/kg orally, once daily for 5 days starting 12h after infection) reduced lung viral load by 1.5 log 10 units versus vehicle at day 2 and to below the limit of detection at day 5. Structure/activity evaluation of additional analogs that have hydrophobic ethers at the sn -2 of glycerol revealed improved in vitro antiviral activity by introduction of a 3-fluoro-4-methoxy-substituted benzyl or a 3- or 4-cyano-substituted benzyl. Collectively, our data support the development of RVn phospholipid prodrugs as oral antiviral agents for prevention and treatment of SARS-CoV-2 infections.
23
Remdesivir for the Treatment of Covid-19 — Final Report
John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.7K citations · Full text
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren, Robert Jordan, Michael K. Lo et al. · Nature · 2016 · 1.6K citations · Full text
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
Robert Gottlieb, Carlos Vaca, Roger Paredes et al. · New England Journal of Medicine · 2021 · 1.3K citations · Full text